醫院管理局藥物名冊 [只備英文版]
版本 21.4 – 自 2026 年 4 月 25 日起生效
2.藥物可有不同劑型或臨床應用，因此部分名冊藥物可能會出現在多個藥物類別。
3.專用藥物需要在特定的臨床應用及臨床情況適用下處方。
4.不同聯網/醫院會按其運作及服務需要，庫存醫管局藥物名冊內適當的藥物。
| 通用藥物 | 專用藥物 | 獲安全網資助的 自費購買藥物(自費藥物) |
不獲安全網資助的 自費藥物 |
|---|---|---|---|
 抗微生物
|
|||
| 通用藥物 | 專用藥物 | 獲安全網資助的 自費購買藥物(自費藥物) |
不獲安全網資助的 自費藥物 |
| ANTIBACTERIAL DRUGS | |||
| AMIKACIN | BEDAQUILINE | ||
| AMINOSALICYLIC ACID | CEFIDEROCOL | ||
| AMOXYCILLIN | CEFTAROLINE | ||
| AMPICILLIN | CEFTAZIDIME + AVIBACTAM | ||
| AUGMENTIN (OR EQUIV) | CEFTOLOZANE + TAZOBACTAM | ||
| AZITHROMYCIN | COLISTIN SULPHOMETHATE SODIUM | ||
| AZTREONAM | DAPTOMYCIN | ||
| BENZATHINE PENICILLIN | DELAMANID | ||
| BENZYLPENICILLIN POTASSIUM | FOSFOMYCIN | ||
| BENZYLPENICILLIN SODIUM | LINEZOLID | ||
| CEFACLOR | POLYMYXIN B SULPHATE | ||
| CEFAZOLIN | RIFAPENTINE | ||
| CEFEPIME | RIFAXIMIN (REFERO) | ||
| CEFOTAXIME | TIGECYCLINE | ||
| CEFOXITIN | |||
| CEFPODOXIME | |||
| CEFTAZIDIME | |||
| CEFTRIAXONE | |||
| CEFUROXIME | |||
| CEPHALEXIN | |||
| CIPROFLOXACIN | |||
| CLARITHROMYCIN | |||
| CLINDAMYCIN | |||
| CLOFAZIMINE | |||
| CLOXACILLIN | |||
| COTRIMOXAZOLE | |||
| CYCLOSERINE | |||
| DAPSONE | |||
| DOXYCYCLINE | |||
| DURLOBACTAM + SULBACTAM | |||
| ERTAPENEM | |||
| ERYTHROMYCIN | |||
| ETHAMBUTOL | |||
| FLUCLOXACILLIN | |||
| FUSIDATE SODIUM | |||
| GENTAMICIN | |||
| ISONIAZID | |||
| KANAMYCIN | |||
| LEVOFLOXACIN | |||
| MEROPENEM | |||
| METRONIDAZOLE | |||
| MINOCYCLINE | |||
| MOXIFLOXACIN | |||
| NEOMYCIN | |||
| NITROFURANTOIN | |||
| OXYTETRACYCLINE + LIGNOCAINE | |||
| PENICILLIN V | |||
| PIPERACILLIN | |||
| PIPERACILLIN + TAZOBACTAM | |||
| PROTHIONAMIDE | |||
| PYRAZINAMIDE | |||
| RIFABUTIN | |||
| RIFAMPICIN | |||
| RIFATER (OR EQUIV) | |||
| RIFINAH (OR EQUIV) | |||
| SODIUM AMINO SALICYLATE | |||
| STREPTOMYCIN | |||
| SULPERAZON (OR EQUIV) | |||
| TEICOPLANIN | |||
| TETRACYCLINE | |||
| TIENAM (OR EQUIV) | |||
| TIMENTIN (OR EQUIV) | |||
| TINIDAZOLE | |||
| TOBRAMYCIN | |||
| TRIMETHOPRIM | |||
| UNASYN (OR EQUIV) | |||
| VANCOMYCIN | |||
| ANTIFUNGAL DRUGS | |||
| 5FLUCYTOSINE | AMPHOTERICIN B (LIPID FORMULATION) | ||
| AMPHOTERICIN B | ANIDULAFUNGIN | ||
| FLUCONAZOLE | CASPOFUNGIN | ||
| GRISEOFULVIN | ISAVUCONAZOLE | ||
| ITRACONAZOLE | MICAFUNGIN | ||
| NYSTATIN | POSACONAZOLE | ||
| TERBINAFINE | VORICONAZOLE | ||
| ANTIVIRAL DRUGS | |||
| ABACAVIR | CIDOFOVIR | LETERMOVIR | |
| ACYCLOVIR | ELBASVIR + GRAZOPREVIR | ||
| ATAZANAVIR | ENTECAVIR | ||
| BIKTARVY (OR EQUIV) | GLECAPREVIR + PIBRENTASVIR | ||
| CABOTEGRAVIR | LAMIVUDINE (ZEFFIX) | ||
| DARUNAVIR | MOLNUPIRAVIR | ||
| DELSTRIGO (OR EQUIV) | NIRMATRELVIR + RITONAVIR | ||
| DOLUTEGRAVIR | NIRSEVIMAB | ||
| DOVATO (OR EQUIV) | OSELTAMIVIR | ||
| EFAVIRENZ | PALIVIZUMAB | ||
| EMTRICITABINE + TENOFOVIR ALAFENAMIDE | REMDESIVIR | ||
| ETRAVIRINE | RIBAVIRIN | ||
| FAMCICLOVIR | SOFOSBUVIR + VELPATASVIR | ||
| FAVIPIRAVIR | TENOFOVIR ALAFENAMIDE FUMARATE | ||
| FOSCARNET | TENOFOVIR DISOPROXIL FUMARATE | ||
| GANCICLOVIR | VOSEVI (OR EQUIV) | ||
| KALETRA | ZANAMIVIR | ||
| KIVEXA (OR EQUIV) | |||
| LAMIVUDINE (3TC) | |||
| LAMIVUDINE + ZIDOVUDINE | |||
| MARAVIROC | |||
| NEVIRAPINE | |||
| ODEFSEY (OR EQUIV) | |||
| PERAMIVIR | |||
| PREZCOBIX (OR EQUIV) | |||
| RALTEGRAVIR | |||
| RIBAVIRIN | |||
| RILPIVIRINE | |||
| RITONAVIR | |||
| SYMTUZA (OR EQUIV) | |||
| TRIUMEQ (OR EQUIV) | |||
| TRUVADA (OR EQUIV) | |||
| VALACICLOVIR | |||
| VALGANCICLOVIR | |||
| ZIDOVUDINE | |||
| ANTIPROTOZOAL DRUGS | |||
| ARTEMETHER + LUMEFANTRINE | |||
| ARTEMISININ + PIPERAQUINE | |||
| ARTESUNATE | |||
| ATOVAQUONE | |||
| CHLOROQUINE PHOSPHATE | |||
| DILOXANIDE | |||
| MALARONE (OR EQUIV) | |||
| MEFLOQUINE | |||
| NITAZOXANIDE | |||
| PENTAMIDINE ISETHIONATE | |||
| PRIMAQUINE (PHOSPHATE) | |||
| PYRIMETHAMINE | |||
| QUININE | |||
| ANTHELMINTICS | |||
| ALBENDAZOLE | |||
| IVERMECTIN | |||
| LEVAMISOLE | |||
| MEBENDAZOLE | |||
| PRAZIQUANTEL | |||
| PYRANTEL PAMOATE | |||
| TRICLABENDAZOLE | |||